EBV-associated diseases: Current therapeutics and emerging technologies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EBV-associated diseases: Current therapeutics and emerging technologies
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-10-27
DOI
10.3389/fimmu.2022.1059133
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM
- (2022) Tobias V. Lanz et al. NATURE
- Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
- (2022) Kjetil Bjornevik et al. SCIENCE
- The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity
- (2022) Sarah M. Morgan et al. Nature Communications
- Virus-like Particles as Preventive and Therapeutic Cancer Vaccines
- (2022) Anna Lucia Tornesello et al. Vaccines
- A study of Ruxolitinib-response-based stratified treatment for pediatric hemophagocytic lymphohistiocytosis
- (2022) Qing Zhang et al. BLOOD
- Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies
- (2022) Xueyi Zheng et al. Viruses-Basel
- How Does Epstein–Barr Virus Interact With Other Microbiomes in EBV-Driven Cancers?
- (2022) Yuxi Wen et al. Frontiers in Cellular and Infection Microbiology
- Treatment Advances in EBV Related Lymphoproliferative Diseases
- (2022) Kebing Lv et al. Frontiers in Oncology
- The Epstein-Barr Virus Hacks Immune Checkpoints: Evidence and Consequences for Lymphoproliferative Disorders and Cancers
- (2022) Alison Felipe Bordini Biggi et al. Biomolecules
- Latent Membrane Proteins from EBV Differentially Target Cellular Pathways to Accelerate MYC-induced Lymphomagenesis
- (2022) Masato Ikeda et al. Blood Advances
- The cytoplasmic LSm1-7 and nuclear LSm2-8 complexes exert opposite effects on Hepatitis B virus biosynthesis and interferon responses
- (2022) Naimur Rahman et al. Frontiers in Immunology
- Time-resolved transcriptomes reveal diverse B cell fate trajectories in the early response to Epstein-Barr virus infection
- (2022) Elliott D. SoRelle et al. Cell Reports
- EBV-Positive Gastric Cancer: Current Knowledge and Future Perspectives
- (2021) Keran Sun et al. Frontiers in Oncology
- Molecular biology of Hodgkin lymphoma
- (2021) Marc A. Weniger et al. LEUKEMIA
- Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution
- (2021) Yang Liu et al. Nature Communications
- Pathologically Relevant Mouse Models for Epstein–Barr Virus–Associated B Cell Lymphoma
- (2021) Shiyu Huang et al. Frontiers in Immunology
- Comprehensive Epstein-Barr Virus Transcriptome by RNA-Sequencing in Angioimmunoblastic T Cell Lymphoma (AITL) and Other Lymphomas
- (2021) Nader Bayda et al. Cancers
- The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy
- (2021) Angela Kwok-Fung Lo et al. Frontiers in Oncology
- The Impact of Epstein-Barr Virus Infection on Epigenetic Regulation of Host Cell Gene Expression in Epithelial and Lymphocytic Malignancies
- (2021) Merrin Man Long Leong et al. Frontiers in Oncology
- EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer
- (2021) Samantha S. Soldan et al. Gastric Cancer
- SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
- (2021) Bingyu Yan et al. Science Immunology
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape
- (2021) Jeff P. Bruce et al. Nature Communications
- Clinicopathological Characteristics and Response to Chemotherapy in Treatment-Naive Epstein–Barr Virus Associated Gastric Cancer: A Retrospective Study
- (2021) Tong Xie et al. Frontiers in Oncology
- Natural Killer Cell Responses during Human γ-Herpesvirus Infections
- (2021) Christian Münz Vaccines
- Estimating the global burden of Epstein–Barr virus-related cancers
- (2021) Yide Wong et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Autocrine vitamin D signaling switches off pro-inflammatory programs of TH1 cells
- (2021) Daniel Chauss et al. NATURE IMMUNOLOGY
- Epstein–Barr Virus Epithelial Cancers—A Comprehensive Understanding to Drive Novel Therapies
- (2021) Shuting Han et al. Frontiers in Immunology
- Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
- (2021) Xinle Cui et al. Frontiers in Immunology
- Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
- (2021) Marcus Bauer et al. Cancers
- Viral Causality of Human Cancer and Potential Roles of Human Endogenous Retroviruses in the Multi-Omics Era: An Evolutionary Epidemiology Review
- (2021) Konstantina Kitsou et al. Frontiers in Oncology
- Single cell RNA-seq reveals the landscape of tumor and infiltrating immune cells in nasopharyngeal cancer
- (2020) Jin Zhao et al. CANCER LETTERS
- Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
- (2020) Enli Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sensitizing Burkitt lymphoma to EBV-CTLs
- (2020) Helen E. Heslop BLOOD
- Vaccination against the Epstein–Barr virus
- (2020) Julia Rühl et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- CD21 (Complement Receptor 2) Is the Receptor for Epstein-Barr Virus Entry into T Cells
- (2020) Nicholas A. Smith et al. JOURNAL OF VIROLOGY
- CAR T-cells that target acute B-lineage leukemia irrespective of CD19 expression
- (2020) Kristen Fousek et al. LEUKEMIA
- KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
- (2020) Michael Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Behavior and Treatment Response of Epstein‐Barr Virus–Positive Metastatic Gastric Cancer: Implications for the Development of Future Trials
- (2020) Salvatore Corallo et al. ONCOLOGIST
- Tenofovir prodrugs potently inhibit Epstein–Barr virus lytic DNA replication by targeting the viral DNA polymerase
- (2020) Natalia C. Drosu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid Tumors
- (2020) Heather Tillman et al. VETERINARY PATHOLOGY
- Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program
- (2020) Massimo Granai et al. Infectious Agents and Cancer
- Deep learning–based cell composition analysis from tissue expression profiles
- (2020) Kevin Menden et al. Science Advances
- Lytic Induction Therapy against Epstein–Barr Virus-Associated Malignancies: Past, Present, and Future
- (2020) Stephanie Pei Tung Yiu et al. Cancers
- Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma
- (2020) Shanzhao Jin et al. CELL RESEARCH
- Epstein-Barr Virus episome physically interacts with active regions of the host genome in lymphoblastoid cells
- (2020) Luopin Wang et al. JOURNAL OF VIROLOGY
- Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990–2017
- (2020) Gulfaraz Khan et al. BMJ Open
- Genome-wide discovery of somatic coding and non-coding mutations in pediatric endemic and sporadic Burkitt lymphoma
- (2019) Bruno M. Grande et al. BLOOD
- Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
- (2019) James P. Dugan et al. Frontiers in Oncology
- Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
- (2019) Wook Youn Kim et al. Frontiers in Pediatrics
- Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas
- (2019) Keisuke Kataoka et al. LEUKEMIA
- Epstein-Barr virus strain variation and cancer
- (2019) Teru Kanda et al. CANCER SCIENCE
- Prophylactic and therapeutic strategies for Epstein–Barr virus-associated diseases: emerging strategies for clinical development
- (2019) Vijayendra Dasari et al. Expert Review of Vaccines
- Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells
- (2019) Wei Bu et al. IMMUNITY
- RNA-seq analyses of gene expression during Epstein-Barr virus infection of primary B lymphocytes
- (2019) Chong Wang et al. JOURNAL OF VIROLOGY
- Essential role of inverted repeat in Epstein–Barr virus IR-1 in B cell transformation; geographical variation of the viral genome
- (2019) Ray Bridges et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Genome sequencing analysis identifies Epstein–Barr virus subtypes associated with high risk of nasopharyngeal carcinoma
- (2019) Miao Xu et al. NATURE GENETICS
- The PD-1/PD-L1 Axis and Virus Infections: A Delicate Balance
- (2019) Günther Schönrich et al. Frontiers in Cellular and Infection Microbiology
- Epstein–Barr Virus and Innate Immunity: Friends or Foes?
- (2019) Sonia Jangra et al. Microorganisms
- Integrated pan-cancer map of EBV-associated neoplasms reveals functional host-virus interactions
- (2019) Srishti Chakravorty et al. CANCER RESEARCH
- The Global Landscape of EBV-Associated Tumors
- (2019) Claire Shannon-Lowe et al. Frontiers in Oncology
- Viral IL‐10 promotes cell proliferation and cell cycle progression via JAK2/STAT3 signaling pathway in nasopharyngeal carcinoma cells
- (2019) Yanxin Ren et al. BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- (2019) Barbara Burtness et al. LANCET
- CD137 Co-Stimulation Improves The Antitumor Effect Of LMP1-Specific Chimeric Antigen Receptor T Cells In Vitro And In Vivo
- (2019) Xiaojun Tang et al. OncoTargets and Therapy
- Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
- (2019) Amit Bar-Or et al. TRENDS IN MOLECULAR MEDICINE
- A novel Epstein–Barr virus-latent membrane protein-1-specific T-cell receptor for TCR gene therapy
- (2018) Hyun-Il Cho et al. BRITISH JOURNAL OF CANCER
- The developmental transcription factor IRF6 attenuates ABCG2 gene expression and distinctively reverses stemness phenotype in nasopharyngeal carcinoma
- (2018) Liang Xu et al. CANCER LETTERS
- Molecular and cellular interplay in virus-induced tumors in solid organ recipients
- (2018) Alessia Gallo et al. CELLULAR IMMUNOLOGY
- CD21-independent Epstein-Barr virus entry into NK cells
- (2018) Jeong Hoo Lee et al. CELLULAR IMMUNOLOGY
- Survival from Childhood Cancers in Eastern Africa: A Population-based registry study
- (2018) W. Yvonne Joko-Fru et al. INTERNATIONAL JOURNAL OF CANCER
- Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
- (2018) Philippe Armand et al. JOURNAL OF CLINICAL ONCOLOGY
- Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity
- (2018) John B. Harley et al. NATURE GENETICS
- Lymphomas driven by Epstein–Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2
- (2018) Sana AlQarni et al. ONCOGENE
- EBV persistence without its EBNA3A and 3C oncogenes in vivo
- (2018) Anita Murer et al. PLoS Pathogens
- Continuous DNA replication is required for late gene transcription and maintenance of replication compartments in gammaherpesviruses
- (2018) Dajiang Li et al. PLoS Pathogens
- Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry
- (2018) Hua Zhang et al. Nature Microbiology
- Ephrin receptor A2 is a functional entry receptor for Epstein–Barr virus
- (2018) Jia Chen et al. Nature Microbiology
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- Genomic characterization of six virus-associated cancers identifies changes in the tumor immune microenvironment and altered genetic programs
- (2018) Frederick S. Varn et al. CANCER RESEARCH
- Antiviral Therapies for Herpesviruses: Current Agents and New Directions
- (2018) Claudette L. Poole et al. CLINICAL THERAPEUTICS
- A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection
- (2018) Jillian A. Bristol et al. PLoS Pathogens
- Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma
- (2018) Katerina Vrzalikova et al. Cancers
- The Epstein–Barr virus LMP1 interactome: biological implications and therapeutic targets
- (2018) Mujeeb R Cheerathodi et al. Future Virology
- Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
- (2018) Rou-Jun Peng et al. LEUKEMIA
- Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma
- (2018) Michaël Cerezo et al. NATURE MEDICINE
- Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice
- (2018) Dwain G. van Zyl et al. PLoS Pathogens
- Intracellular Iron Chelation by a Novel Compound, C7, Reactivates Epstein–Barr Virus (EBV) Lytic Cycle via the ERK-Autophagy Axis in EBV-Positive Epithelial Cancers
- (2018) Stephanie Yiu et al. Cancers
- Epstein–Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review
- (2017) Joana Ribeiro et al. Future Oncology
- Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols
- (2017) Marius Rohde et al. HAEMATOLOGICA
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
- (2017) Chiun Hsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
- (2017) Anshuman Panda et al. JNCI-Journal of the National Cancer Institute
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type–Specific Differences
- (2017) Yasin Kaymaz et al. MOLECULAR CANCER RESEARCH
- Epstein–Barr virus-associated lymphomas
- (2017) Claire Shannon-Lowe et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
- (2017) Yvonne Y Li et al. Nature Communications
- Chromatin reorganisation in Epstein-Barr virus-infected cells and its role in cancer development
- (2017) Michelle J West Current Opinion in Virology
- Humanized mouse models for Epstein Barr virus infection
- (2017) Christian Münz Current Opinion in Virology
- Hypoxia-inducible factor-1α plays roles in Epstein-Barr virus’s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter
- (2017) Richard J. Kraus et al. PLoS Pathogens
- LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma
- (2017) Ting-Ting Cai et al. PLoS Pathogens
- Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols
- (2017) Marius Rohde et al. HAEMATOLOGICA
- Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis
- (2017) Jiewei Chen et al. Journal of Cancer
- Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer
- (2017) Anshuman Panda et al. JNCI-Journal of the National Cancer Institute
- Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus
- (2017) Atsushi Okabe et al. Scientific Reports
- IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma
- (2017) Ji Wook Moon et al. Scientific Reports
- Tenofovir alafenamide (TAF) as the successor of tenofovir disoproxil fumarate (TDF)
- (2016) Erik De Clercq BIOCHEMICAL PHARMACOLOGY
- Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
- (2016) J. Styczynski et al. HAEMATOLOGICA
- Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study
- (2016) Geoffrey Buckle et al. INTERNATIONAL JOURNAL OF CANCER
- PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome
- (2016) Margaretha G.M. Roemer et al. JOURNAL OF CLINICAL ONCOLOGY
- Computational analysis of EBNA1 “druggability” suggests novel insights for Epstein-Barr virus inhibitor design
- (2016) Eleonora Gianti et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells
- (2016) Jens S. Kalchschmidt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma
- (2016) Xi-wen Bi et al. Journal of Hematology & Oncology
- Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers
- (2016) Keisuke Kataoka et al. NATURE
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression
- (2016) Kostas Paschos et al. NUCLEIC ACIDS RESEARCH
- The BDLF3 gene product of Epstein-Barr virus , gp150, mediates non-productive binding to heparan sulfate on epithelial cells and only the binding domain of CD21 is required for infection
- (2016) Liudmila S. Chesnokova et al. VIROLOGY
- From Conventional to Next Generation Sequencing of Epstein-Barr Virus Genomes
- (2016) Hin Kwok et al. Viruses-Basel
- Novel Epstein-Barr virus-like particles incorporating gH/gL-EBNA1 or gB-LMP2 induce high neutralizing antibody titers and EBV-specific T-cell responses in immunized mice
- (2016) Elizabeth M. Perez et al. Oncotarget
- The Link between Plasmodium falciparum Malaria and Endemic Burkitt’s Lymphoma—New Insight into a 50-Year-Old Enigma
- (2016) David Thorley-Lawson et al. PLoS Pathogens
- Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
- (2016) Jill M. Brooks et al. PLoS Pathogens
- MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs
- (2016) C David Wood et al. eLife
- Management of Epstein-Barr Virus infections and post-transplant lymphoproliferative disorders in patients after allogeneic hematopoietic stem cell transplantation: Sixth European Conference on Infections in Leukemia (ECIL-6) guidelines
- (2016) J. Styczynski et al. HAEMATOLOGICA
- Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial
- (2016) Joel E Gallant et al. Lancet HIV
- Epstein–Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsin
- (2015) S. J. Kim et al. ANNALS OF ONCOLOGY
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site
- (2015) Masaru Kanekiyo et al. CELL
- A chimeric EBV gp350/220-based VLP replicates the virion B-cell attachment mechanism and elicits long-lasting neutralizing antibodies in mice
- (2015) Javier Ogembo et al. Journal of Translational Medicine
- Epstein–Barr Virus Infection and Gastric Cancer
- (2015) Xin-Zu Chen et al. MEDICINE
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive assembly of novel transcripts from unmapped human RNA-Seq data and their association with cancer
- (2015) M. Kazemian et al. Molecular Systems Biology
- Epstein–Barr virus transcription factor Zta acts through distal regulatory elements to directly control cellular gene expression
- (2015) Sharada Ramasubramanyan et al. NUCLEIC ACIDS RESEARCH
- Epstein-Barr Virus-Associated Gastric Carcinoma: Use of Host Cell Machineries and Somatic Gene Mutations
- (2015) Hiroyuki Abe et al. PATHOBIOLOGY
- Accumulation Mechanisms of CD4+CD25+FOXP3+ Regulatory T Cells in EBV-associated Gastric Carcinoma
- (2015) Na-na Zhang et al. Scientific Reports
- Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma
- (2015) Francesco Abate et al. PLoS Pathogens
- Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus-Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
- (2015) Y. Zheng et al. Cancer Immunology Research
- Comparison of variations detection between whole-genome amplification methods used in single-cell resequencing
- (2015) Yong Hou et al. GigaScience
- Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies
- (2015) Chung King Choi et al. PLoS One
- EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
- (2015) Wenfeng Fang et al. Oncotarget
- Small molecule inhibition of Epstein–Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome
- (2014) Eun Kyung Lee et al. ANTIVIRAL RESEARCH
- Not like a wrecking ball: EBV fine-tunes MYC lymphomagenesis
- (2014) D. P. Dittmer BLOOD
- A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein-Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer
- (2014) G. S. Taylor et al. CLINICAL CANCER RESEARCH
- Integrative Identification of Epstein–Barr Virus–Associated Mutations and Epigenetic Alterations in Gastric Cancer
- (2014) Qiaoyi Liang et al. GASTROENTEROLOGY
- Genome-Wide Analysis of Wild-Type Epstein–Barr Virus Genomes Derived from Healthy Individuals of the 1000 Genomes Project
- (2014) Gabriel Santpere et al. Genome Biology and Evolution
- Tuning of Antigen Sensitivity by T Cell Receptor-Dependent Negative Feedback Controls T Cell Effector Function in Inflamed Tissues
- (2014) Tetsuya Honda et al. IMMUNITY
- Effect of Nasopharyngeal Carcinoma-Derived Exosomes on Human Regulatory T Cells
- (2014) Dhafer Mrizak et al. JNCI-Journal of the National Cancer Institute
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- The genomic landscape of nasopharyngeal carcinoma
- (2014) De-Chen Lin et al. NATURE GENETICS
- Epstein–Barr virus replicating in epithelial cells
- (2014) Lindsey M. Hutt-Fletcher PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of the latent-lytic switch in Epstein–Barr virus
- (2014) Shannon C. Kenney et al. SEMINARS IN CANCER BIOLOGY
- Cancer “Causation” by Infections—Individual Contributions and Synergistic Networks
- (2014) Harald zur Hausen et al. SEMINARS IN ONCOLOGY
- Oncogenic Mechanisms in Burkitt Lymphoma
- (2014) R. Schmitz et al. Cold Spring Harbor Perspectives in Medicine
- Epstein Barr virus entry; kissing and conjugation
- (2014) Claire Shannon-Lowe et al. Current Opinion in Virology
- Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010
- (2014) Gulfaraz Khan et al. Infectious Agents and Cancer
- Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disorder
- (2013) M. Green et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Epstein-Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979-2009
- (2013) Sam M. Mbulaiteye et al. APMIS
- Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases
- (2013) L. J. Costa et al. BLOOD
- Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma
- (2013) K. Fish et al. BLOOD
- PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
- (2013) B. J. Chen et al. CLINICAL CANCER RESEARCH
- Infectious diseases in humanized mice
- (2013) Carol Leung et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
- (2013) Catherine M. Bollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Landscape of DNA Virus Associations across Human Malignant Cancers: Analysis of 3,775 Cases Using RNA-Seq
- (2013) J. D. Khoury et al. JOURNAL OF VIROLOGY
- Adoptive T-cell Transfer and Chemotherapy in the First-line Treatment of Metastatic and/or Locally Recurrent Nasopharyngeal Carcinoma
- (2013) Whay-Kuang Chia et al. MOLECULAR THERAPY
- A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
- (2013) Taku Okazaki et al. NATURE IMMUNOLOGY
- Switching of EBV cycles between latent and lytic states
- (2013) Takayuki Murata et al. REVIEWS IN MEDICAL VIROLOGY
- The need and challenges for development of an Epstein-Barr virus vaccine
- (2013) Jeffrey I. Cohen et al. VACCINE
- The landscape of viral expression and host gene fusion and adaptation in human cancer
- (2013) Ka-Wei Tang et al. Nature Communications
- Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas
- (2013) Ming-Han Tsai et al. Cell Reports
- Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
- (2013) Obinna Chijioke et al. Cell Reports
- Nonhuman primate models for Epstein-Barr virus infection
- (2013) Fred Wang Current Opinion in Virology
- Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant Therapy
- (2013) Michael J. Strong et al. PLoS Pathogens
- Small molecule and peptide-mediated inhibition of Epstein-Barr virus nuclear antigen 1 dimerization
- (2012) Sun Young Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes
- (2012) L. Giulino-Roth et al. BLOOD
- Epidemiology: clues to the pathogenesis of Burkitt lymphoma
- (2012) Ian Magrath BRITISH JOURNAL OF HAEMATOLOGY
- Synergy between PI3K Signaling and MYC in Burkitt Lymphomagenesis
- (2012) Sandrine Sander et al. CANCER CELL
- Epstein-Barr Virus Infection as an Epigenetic Driver of Tumorigenesis
- (2012) A. Kaneda et al. CANCER RESEARCH
- Effective Treatment of Metastatic Forms of Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma with a Novel Adenovirus-Based Adoptive Immunotherapy
- (2012) C. Smith et al. CANCER RESEARCH
- Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model
- (2012) Baochun Zhang et al. CELL
- An Atlas of the Epstein-Barr Virus Transcriptome and Epigenome Reveals Host-Virus Regulatory Interactions
- (2012) Aaron Arvey et al. Cell Host & Microbe
- Cytolytic Virus Activation Therapy for Epstein-Barr Virus-Driven Tumors
- (2012) M. A. Wildeman et al. CLINICAL CANCER RESEARCH
- Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
- (2012) M. R. Green et al. CLINICAL CANCER RESEARCH
- The Activation of MAPK in Melanoma Cells Resistant to BRAF Inhibition Promotes PD-L1 Expression That Is Reversible by MEK and PI3K Inhibition
- (2012) X. Jiang et al. CLINICAL CANCER RESEARCH
- Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma
- (2012) K.F. Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Hodgkin lymphoma
- (2012) Ralf Küppers et al. JOURNAL OF CLINICAL INVESTIGATION
- Inhibition of Latent Membrane Protein 1 Impairs the Growth and Tumorigenesis of Latency II Epstein-Barr Virus-Transformed T Cells
- (2012) P. A. Ndour et al. JOURNAL OF VIROLOGY
- Viral Genome Methylation Differentially Affects the Ability of BZLF1 versus BRLF1 To Activate Epstein-Barr Virus Lytic Gene Expression and Viral Replication
- (2012) C. K. Wille et al. JOURNAL OF VIROLOGY
- An Epstein-Barr Virus Mutant Produces Immunogenic Defective Particles Devoid of Viral DNA
- (2012) S. Pavlova et al. JOURNAL OF VIROLOGY
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
- (2012) Catherine de Martel et al. LANCET ONCOLOGY
- Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics
- (2012) Roland Schmitz et al. NATURE
- The genetic landscape of mutations in Burkitt lymphoma
- (2012) Cassandra Love et al. NATURE GENETICS
- Quantification of Epstein-Barr Virus DNA Is Helpful for Evaluation of Chronic Active Epstein-Barr Virus Infection
- (2012) Yuichi Sakamoto et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- (Val-)Ganciclovir prophylaxis reduces Epstein-Barr virus primary infection in pediatric renal transplantation
- (2012) Britta Höcker et al. TRANSPLANT INTERNATIONAL
- Contributions of Epstein–Barr Nuclear Antigen 1 (EBNA1) to Cell Immortalization and Survival
- (2012) Lori Frappier Viruses-Basel
- Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
- (2012) Hisashi Iizasa et al. Viruses-Basel
- BZLF1 Governs CpG-Methylated Chromatin of Epstein-Barr Virus Reversing Epigenetic Repression
- (2012) Anne Woellmer et al. PLoS Pathogens
- Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents
- (2011) S. K. Ghosh et al. BLOOD
- Infectious agents in human cancers: Lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV
- (2011) Graham S. Taylor et al. CANCER LETTERS
- Epstein-Barr Virus-Associated B-cell Lymphomas: Pathogenesis and Clinical Outcomes
- (2011) A. Saha et al. CLINICAL CANCER RESEARCH
- Contributions of the Epstein-Barr Virus EBNA1 Protein to Gastric Carcinoma
- (2011) N. Sivachandran et al. JOURNAL OF VIROLOGY
- Valproic Acid Antagonizes the Capacity of Other Histone Deacetylase Inhibitors To Activate the Epstein-Barr Virus Lytic Cycle
- (2011) D. Daigle et al. JOURNAL OF VIROLOGY
- Changes in the Nasopharyngeal Carcinoma Nuclear Proteome Induced by the EBNA1 Protein of Epstein-Barr Virus Reveal Potential Roles for EBNA1 in Metastasis and Oxidative Stress Responses
- (2011) J. Y. Cao et al. JOURNAL OF VIROLOGY
- A Virus-Like Particle-Based Epstein-Barr Virus Vaccine
- (2011) R. Ruiss et al. JOURNAL OF VIROLOGY
- A Human Fab-Based Immunoconjugate Specific for the LMP1 Extracellular Domain Inhibits Nasopharyngeal Carcinoma Growth In Vitro and In Vivo
- (2011) R. Chen et al. MOLECULAR CANCER THERAPEUTICS
- In situ expression of the CCL20-CCR6 axis in lymphocyte-rich gastric cancer and its potential role in the formation of lymphoid stroma
- (2011) Haruo Ohtani et al. PATHOLOGY INTERNATIONAL
- Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
- (2011) J. I. Cohen et al. Science Translational Medicine
- Potential role of LMP2 as tumor-suppressor defines new targets for uterine leiomyosarcoma therapy
- (2011) Takuma Hayashi et al. Scientific Reports
- Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma
- (2010) M. R. Green et al. BLOOD
- Lymphomas differ in their dependence on Epstein-Barr virus
- (2010) D. T. Vereide et al. BLOOD
- Virus-like particles in vaccine development
- (2010) António Roldão et al. Expert Review of Vaccines
- Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma
- (2010) Chrystal U. Louis et al. JOURNAL OF IMMUNOTHERAPY
- Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China
- (2010) Jian-Ning Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation
- (2010) Robert Valentine et al. Molecular Cancer
- A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci
- (2010) Jin-Xin Bei et al. NATURE GENETICS
- Infectious Mononucleosis
- (2010) Katherine Luzuriaga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extensive Co-Operation between the Epstein-Barr Virus EBNA3 Proteins in the Manipulation of Host Gene Expression and Epigenetic Chromatin Modification
- (2010) Robert E. White et al. PLoS One
- Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines
- (2010) B. Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cellular factors associated with latency and spontaneous Epstein–Barr virus reactivation in B-lymphoblastoid cell lines
- (2010) Michael L. Davies et al. VIROLOGY
- Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
- (2009) H. E. Heslop et al. BLOOD
- Mutations ofNFKBIA, encoding IκBα, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases
- (2009) Annette Lake et al. INTERNATIONAL JOURNAL OF CANCER
- Suberoylanilide hydroxamic acid induces viral lytic cycle in Epstein-Barr virus-positive epithelial malignancies and mediates enhanced cell death
- (2009) K.F. Hui et al. INTERNATIONAL JOURNAL OF CANCER
- Lymphocryptovirus phylogeny and the origins of Epstein-Barr virus
- (2009) B. Ehlers et al. JOURNAL OF GENERAL VIROLOGY
- A review of human carcinogens—Part B: biological agents
- (2009) Véronique Bouvard et al. LANCET ONCOLOGY
- mRNA-Seq whole-transcriptome analysis of a single cell
- (2009) Fuchou Tang et al. NATURE METHODS
- Chronic Fatigue Syndrome After Infectious Mononucleosis in Adolescents
- (2009) B. Z. Katz et al. PEDIATRICS
- Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins v 6 or v 8
- (2009) L. S. Chesnokova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
- (2009) Martin J. Allday SEMINARS IN CANCER BIOLOGY
- Differential Gene Expression Patterns of EBV Infected EBNA-3A Positive and Negative Human B Lymphocytes
- (2009) Marie L. Hertle et al. PLoS Pathogens
- Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells
- (2008) Karl R.N. Baumforth et al. AMERICAN JOURNAL OF PATHOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- HIV-associated lymphomas and gamma-herpesviruses
- (2008) A. Carbone et al. BLOOD
- AID expression levels determine the extent ofcMyconcogenic translocations and the incidence of B cell tumor development
- (2008) Makiko Takizawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival
- (2008) P. Tsimbouri et al. JOURNAL OF GENERAL VIROLOGY
- Activation of the ERK signal transduction pathway by Epstein-Barr virus immediate-early protein Rta
- (2008) Y.-H. Lee et al. JOURNAL OF GENERAL VIROLOGY
- Treatment of locally recurrent epstein–barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir
- (2008) Tomokazu Yoshizaki et al. JOURNAL OF MEDICAL VIROLOGY
- Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients
- (2008) Floor Pietersma et al. LEUKEMIA & LYMPHOMA
- Epstein–Barr virus-encoded small RNA induces IL-10 through RIG-I-mediated IRF-3 signaling
- (2008) M Samanta et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started